Part of Phaidon International
Part of Phaidon International
Showing 21 results
Sort by:
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...
Title: Director, Clinical PharmacologyLocation: Greater Philadelphia Area (Hybrid)A growing biotechnology company is seeking a Director of Clinical Pharmacology to drive clinical pharmacology and MIDD strategies across its pipeline. This role will be responsible for supporting programs from Phase 1 through registration, leveraging quantitative phar...
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...
Sustaining Engineer | Medical Device IndustryJoin a growing medical device company where you'll play a key role in supporting and improving products that make a real impact on patient care. This is a highly visible position offering exposure to product development, manufacturing, quality, regulatory, and supplier management activities. What You'll ...
Product Development Engineer - Cutting-Edge MedTechJoin a rapidly advancing medtech team delivering breakthrough, minimally invasive technologies that are redefining standards of care in cardiovascular treatment. What you'll do:Own V&V testing, prototyping, and hands-on lab workDrive development from concept through product launchContribute to desi...
Senior Clinical Trial Manager | Waltham, MA$150k-$185kOur client is a well-funded, publicly traded clinical-stage biotechnology company developing next-generation biologics for chronic inflammatory diseases. With multiple late-stage clinical programs and substantial capital to support growth, the organization is entering an exciting phase of expans...